Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

A Phase 2, Open-label, Single-arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

Holden Comprehensive Cancer Center

Cancer Internal Medicine Lymphoma Adult Subjects

Principal investigator

Umar Farooq

Internal Medicine

View other research studies by Umar Farooq

Participate in this trial

Are you interested in enrolling in this study? Learn more here.

I'm Interested In Participating

Details

IRB Number

202409556

NCT Number

NCT

Study Status

Open

Currently Recruiting

Yes

Study Type

Interventional

Cancer Study

Yes

Compensation Available

Yes